We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
PKM is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
876.9
Number of samples
349
Samples
Sample
Description
TPM
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
3248.9
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
3146.4
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
3051.4
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
2891.9
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
2432.2
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
2390.5
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
2271.5
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
2242.0
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
2239.7
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
1971.4
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
1955.2
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
1928.6
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
1918.4
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
1917.0
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
1876.2
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
1850.1
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
1818.0
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
1797.2
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
1762.7
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
1762.0
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
1736.9
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
1706.4
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
1704.0
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
1702.2
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
1698.8
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
1621.1
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
1605.5
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
1545.5
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
1544.8
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
1533.0
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
1525.8
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
1501.4
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
1447.7
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
1428.1
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
1422.3
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
1403.0
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
1360.9
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
1333.8
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
1328.3
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
1323.5
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
1323.3
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
1320.5
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
1320.2
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
1311.4
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
1308.6
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
1307.7
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
1302.5
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
1290.8
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
1287.0
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
1284.7
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
1275.0
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
1260.5
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
1253.0
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
1249.1
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
1241.0
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
1233.7
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
1230.1
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
1217.4
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
1214.4
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
1209.1
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
1202.8
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
1200.4
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
1191.8
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
1181.7
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
1176.8
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
1175.5
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
1170.6
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
1170.0
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
1164.6
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
1149.5
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
1144.1
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
1141.4
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
1135.9
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
1123.6
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
1114.8
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
1112.9
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
1111.8
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
1104.8
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
1104.2
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
1092.2
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
1091.2
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
1090.7
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
1089.6
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
1064.7
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
1062.1
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
1057.7
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
1054.8
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
1054.4
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
1049.9
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
1048.9
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
1046.7
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
1039.9
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
1037.3
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
1036.6
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
1030.8
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
1025.5
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
1021.6
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
1006.1
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
1005.9
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
1005.3
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
1003.2
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
997.3
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
995.6
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
993.3
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
978.9
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
972.8
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
967.3
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
965.5
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
964.1
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
961.1
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
959.8
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
959.4
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
945.4
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
926.2
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
924.6
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
916.9
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
916.8
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
910.2
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
906.9
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
906.8
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
903.3
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
900.1
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
899.8
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
898.6
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
898.4
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
897.1
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
897.1
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
896.0
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
895.6
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
894.5
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
894.5
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
893.7
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
892.8
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
887.8
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
884.7
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
880.7
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
876.2
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
873.6
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
870.3
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
869.1
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
867.5
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
865.5
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
853.8
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
845.8
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
845.6
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
840.4
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
838.7
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
834.7
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
834.6
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
831.6
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
830.0
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
829.6
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
828.9
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
828.8
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
826.5
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
825.6
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
824.7
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
824.0
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
817.4
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
815.8
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
812.4
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
805.8
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
800.8
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
799.5
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
795.2
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
792.8
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
790.2
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
789.9
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
789.8
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
788.0
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
786.9
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
779.7
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
775.7
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
764.4
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
759.0
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
758.2
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
756.5
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
752.8
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
751.3
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
750.9
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
750.4
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
749.9
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
749.7
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
748.8
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
747.2
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
747.2
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
740.9
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
738.1
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
731.1
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
725.3
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
724.3
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
723.8
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
720.9
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
719.1
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
718.8
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
717.4
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
713.4
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
712.4
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
710.8
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
699.8
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
699.1
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
698.9
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
697.8
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
695.3
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
694.5
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
694.5
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
688.7
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
686.3
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
683.4
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
677.8
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
676.0
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
671.1
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
667.7
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
667.3
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
664.6
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
663.6
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
660.8
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
656.6
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
656.4
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
649.6
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
648.6
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
647.2
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
646.5
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
640.5
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
635.0
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
634.8
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
632.5
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
631.8
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
630.6
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
630.1
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
627.6
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
627.3
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
624.7
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
618.3
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
616.9
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
614.0
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
612.7
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
604.3
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
601.6
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
600.4
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
599.5
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
597.9
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
595.8
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
595.2
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
594.5
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
590.8
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
584.9
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
582.9
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
574.9
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
574.6
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
574.0
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
569.9
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
566.1
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
561.5
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
561.4
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
560.8
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
560.1
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
557.9
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
557.6
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
555.5
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
553.1
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
552.1
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
549.2
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
548.3
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
542.9
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
541.2
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
540.0
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
537.6
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
537.5
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
533.1
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
532.2
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
528.1
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
524.7
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
524.5
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
521.1
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
517.4
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
517.3
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
515.4
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
514.1
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
513.1
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
509.6
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
507.9
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
507.0
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
506.4
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
505.7
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
505.4
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
504.1
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
503.6
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
501.4
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
500.8
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
499.6
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
497.8
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
497.3
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
494.2
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
493.1
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
486.9
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
486.4
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
482.5
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
480.1
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
478.7
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
476.3
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
475.6
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
474.3
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
474.0
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
472.8
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
468.0
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
467.7
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
466.8
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
466.8
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
462.8
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
460.9
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
457.9
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
457.8
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
448.6
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
446.6
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
446.6
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
444.6
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
442.1
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
439.8
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
438.1
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
437.9
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
436.5
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
434.5
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
433.1
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
431.7
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
425.1
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
418.3
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
415.9
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
413.7
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
407.7
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
404.7
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
393.8
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
393.2
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
386.2
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
385.8
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
382.9
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
382.0
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
379.2
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
376.9
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
370.0
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
366.6
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
351.6
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
350.7
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
331.6
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
331.0
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
276.0
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
202.4
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
170.9
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
PKM is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
711.7
Number of samples
81
Samples
Sample
Description
TPM
DO46404
0 years, female, NA, stage:III, dead, 690 days
1741.7
DO46354
0 years, female, NA, stage:III, dead, 843 days
1657.7
DO46332
0 years, female, NA, stage:III, dead, 689 days
1646.1
DO46551
0 years, female, NA, stage:III, dead, 1055 days
1493.3
DO46533
0 years, female, NA, stage:III, alive, 3667 days
1448.8
DO46327
0 years, female, NA, stage:III, dead, 184 days
1341.9
DO46346
0 years, female, NA, stage:III, dead, 1187 days
1185.1
DO46336
0 years, female, NA, stage:IV, dead, 664 days
1169.0
DO46368
0 years, female, NA, stage:III, dead, 2879 days
1162.2
DO46326
0 years, female, NA, stage:III, dead, 701 days
1129.3
DO46538
0 years, female, NA, stage:III, dead, 1527 days
1041.7
DO46508
0 years, female, NA, stage:III, dead, 2101 days
1034.2
DO46518
0 years, female, NA, stage:III, alive, 2960 days
1003.2
DO46586
0 years, female, NA, stage:III, dead, 1019 days
986.5
DO46382
0 years, female, NA, stage:IV, dead, 311 days
959.3
DO46362
0 years, female, NA, stage:III, dead, 1639 days
904.7
DO46376
0 years, female, NA, stage:III, dead, 1430 days
854.1
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
850.7
DO46566
0 years, female, NA, stage:III, dead, 673 days
816.8
DO46340
0 years, female, NA, stage:III, dead, 616 days
813.9
DO46348
0 years, female, NA, stage:IV, dead, 287 days
812.2
DO46448
0 years, female, NA, stage:III, dead, 654 days
807.3
DO46338
0 years, female, NA, stage:III, dead, 596 days
802.3
DO46388
0 years, female, NA, stage:III, dead, 413 days
797.6
DO46606
0 years, female, NA, stage:III, alive, 804 days
789.2
DO46330
0 years, female, NA, stage:III, dead, 684 days
783.9
DO46344
0 years, female, NA, stage:III, dead, 642 days
769.4
DO46352
0 years, female, NA, stage:III, dead, 677 days
763.9
DO46571
0 years, female, NA, stage:III, dead, 243 days
758.8
DO46432
0 years, female, NA, stage:III, alive, 2218 days
750.8
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
750.6
DO46581
0 years, female, NA, stage:III, dead, 408 days
746.4
DO46568
0 years, female, NA, stage:III, dead, 320 days
741.8
DO46364
0 years, female, NA, stage:III, dead, 806 days
725.6
DO46380
0 years, female, NA, stage:III, dead, 1423 days
721.2
DO46328
0 years, female, NA, stage:III, dead, 972 days
715.3
DO46528
0 years, female, NA, stage:III, alive, 6139 days
686.0
DO46358
0 years, female, NA, stage:III, dead, 423 days
666.5
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
666.2
DO46378
0 years, female, NA, stage:III, alive, 843 days
652.4
DO46325
0 years, female, NA, stage:III, dead, 477 days
650.6
DO46329
0 years, female, NA, stage:III, dead, 1699 days
649.4
DO46370
0 years, female, NA, stage:III, dead, 1727 days
624.4
DO46468
0 years, female, NA, stage:III, alive, 2776 days
619.7
DO46443
0 years, female, NA, stage:III, dead, 2464 days
615.6
DO46333
0 years, female, NA, stage:III, dead, 359 days
605.3
DO46386
0 years, female, NA, stage:III, dead, 1162 days
602.0
DO46560
0 years, female, NA, stage:IV, dead, 286 days
591.0
DO46396
0 years, female, NA, stage:III, dead, 583 days
584.6
DO46453
0 years, female, NA, stage:III, dead, 3294 days
573.2
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
560.3
DO46436
0 years, female, NA, stage:III, alive, 3193 days
556.9
DO46372
0 years, female, NA, stage:III, dead, 1326 days
554.7
DO46331
0 years, female, NA, stage:III, dead, 612 days
546.0
DO46408
0 years, female, NA, stage:III, dead, 489 days
545.1
DO46374
0 years, female, NA, stage:III, dead, 1409 days
538.1
DO46493
0 years, female, NA, stage:IV, alive, 839 days
517.3
DO46588
0 years, female, NA, stage:III, dead, 438 days
513.3
DO46334
0 years, female, NA, stage:III, dead, 496 days
499.3
DO46597
0 years, female, NA, stage:III, dead, 393 days
499.2
DO46412
0 years, female, NA, stage:III, dead, 597 days
497.6
DO46602
0 years, female, NA, stage:III, dead, 205 days
484.1
DO46366
0 years, female, NA, stage:III, dead, 2054 days
474.1
DO46398
0 years, female, NA, stage:III, alive, 437 days
471.3
DO46546
0 years, female, NA, stage:III, dead, 1889 days
459.2
DO46350
0 years, female, NA, stage:III, dead, 886 days
454.3
DO46342
0 years, female, NA, stage:III, dead, 1398 days
449.7
DO46591
0 years, female, NA, stage:III, dead, 195 days
437.5
DO46402
0 years, female, NA, stage:III, dead, 511 days
426.1
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
421.9
DO46463
0 years, female, NA, stage:III, dead, 2451 days
421.2
DO46561
0 years, female, NA, stage:III, dead, 195 days
416.9
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
404.7
DO46576
0 years, female, NA, stage:III, alive, 133 days
396.9
DO46400
0 years, female, NA, stage:III, dead, 719 days
337.9
DO46392
0 years, female, NA, stage:III, dead, 628 days
327.0
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
284.6
DO46384
0 years, female, NA, stage:III, dead, 614 days
254.7
DO46390
0 years, female, NA, stage:III, dead, 374 days
251.4
DO46356
0 years, female, NA, stage:III, dead, 911 days
233.0
DO46611
0 years, female, NA, stage:III, dead, 734 days
150.8
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.9
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.9
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
0.9
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
0.8
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.8
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.8
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.7
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
0.6
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.6
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.6
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.6
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
0.6
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.6
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.6
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.5
15524912-685a-47ce-a824-567848_D2
Tumor
0.5
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
0.5
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.5
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.5
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.5
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.5
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.5
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.5
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.5
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.5
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.5
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.5
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.4
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.4
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.4
e9d416e7-f661-400a-896e-388545_D2
Tumor
0.4
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.4
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.4
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.4
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
0.4
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
0.4
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.3
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
0.3
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
0.3
a3a26070-fb84-406a-8280-d555e6_D2
Normal
0.3
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.3
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.3
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.3
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.3
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.3
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.3
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.3
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.2
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.2
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.2
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
0.2
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.2
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.2
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
0.2
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.2
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.2
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.2
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.2
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.2
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.1
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.1
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.1
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.1
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
0.1
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.1
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.1
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.0
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.0
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.0
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.0
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.0
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.0
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
0.0
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
0.0
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.0
21efd60f-6a31-4b98-9477-16a905_D2
Normal
0.0
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
0.0
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
0.0
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
0.0
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.0
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-0.1
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
-0.1
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-0.1
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.1
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.1
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-0.1
340a3769-3031-41ae-bb08-a2f696_D2
Normal
-0.1
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-0.1
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.1
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
-0.2
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.2
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.2
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.2
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-0.2
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.2
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.3
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.3
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.3
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-0.3
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.3
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.3
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.3
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.3
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
-0.3
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.3
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.4
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.4
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.